Iodinated Contrast Media in Interventional X-Ray Market Research Report and Overview

1
Iodinated Contrast Media in Interventional X-Ray
Market Research Report and Overview
Iodinated Contrast Media in Interventional X-Ray
Market By Route of Administration (Intravenous,
Oral, Rectal, Others), Indication (Cardiology,
Neurology, General Surgery, Oncology, Urology),
Agent Type (Non-Ionic, Ionic), End User
(Hospital, Specialty Clinics, Diagnostic Centers,
Ambulatory Surgical Centers, Research Academic
Institutes), Country ( U.S., Canada, Mexico,,
Germany, U.K., France, Italy, Spain, Switzerland,
Netherlands, Russia, Belgium, Turkey, Rest Of
Europe, China, Japan, South Korea, India,
Australia, Singapore, Thailand, Malaysia,
Indonesia, Philippines, Rest of Asia-Pacific,
Brazil, Argentina, Peru, Rest of South America,
UAE, Saudi Arabia, Egypt, South Africa, Israel,
Rest of Middle East and Africa) Market Trends and
 Forecast to 2027
Browse Full Report https//www.databridgemarke
tresearch.com/reports/global-iodinated-contrast-me
dia-in-interventional-x-ray-market
2
Market Analysis and Insights
Increasing prevalence of chronic disease such as
growing preference for interventional diagnosis
across the globe has increased the adoption of
iodinated contrast media. For instance, According
to World Health Organization, there were an
estimated 17.9 million deaths in 2016 due to
cardiovascular diseases cardiovascular diseases
are one of the main causes of deaths around the
world. Growing preference towards iodinated
contrast media from traditional contrast media
and large number of approvals for iodinated
agents will drive the market and create new
opportunities for the growth during the forecast
period. For instance, In March 2017, the Food and
Drug Administration (FDA) approved GE Healthcare
Visipaque (iodixanol) imaging agent. The need for
diagnostic imaging has increased resulting to the
contribution to the medical costs and also by
providing exposure to the ionizing radiation.
Get Exclusive Sample Report https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-iodinated-contrast-media-in-interventional-x-ray
-market
3
Image
4
Major Key Players

• Some of the major players operating in this
  market are
• Bayer AG
• Iso-Tex Diagnostics, Inc.
• Bracco Diagnostic Inc
• Novalek Pharmaceuticals Pvt. Ltd.
• iMAX
• Taejoon Pharm
• Unijules Medicals Ltd
• General Electric
• Guerbet LLC

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
iodinated-contrast-media-in-interventional-x-ray-m
arket
5
Market Segmentation

• By Route of Administration (Intravenous, Oral,
  Rectal, Others)
• By Agent Type (Non-Ionic, Ionic)
• By End User (Hospital, Specialty Clinics,
  Diagnostic Centers, Ambulatory Surgical Centers,
  Research Academic Institutes)

Browse Full TOC _at_ https//www.databridgemarketre
search.com/toc/?dbmrglobal-iodinated-contrast-med
ia-in-interventional-x-ray-market
6
Regional Analysis

• Based on geography, the market is segmented into
  five geographical regions
• North America
• Europe
• Asia-Pacific
• South America
• Middle East
• Africa

7
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com